Cataract Surgery and its Complications in Diabetic Patients

REFERENCES

• International Diabetes Federation. IDF Diabetes Atlas, 6th ed.; Brussels: International Diabetes Federation, 2013. Available at: http://www.idf.org/diabetesatlas
   Google Scholar
• Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol 2003;136(1):122–135
   PubMed Web of Science ®Google Scholar
• Erie JC. Rising cataract surgery rates: demand and supply. Ophthalmology 2014;121(1):2–4
   PubMedGoogle Scholar
• Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96(5):614–8
   PubMed Web of Science ®Google Scholar
• Hashim Z, Zarina S. Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. Age (Dordr) 2011;33(3):377–84
   PubMedGoogle Scholar
• Sensi M, Pricci F, Pugliese G, et al. Role of advanced glycation end-products (AGE) in late diabetic complications. Diabetes Res Clin Pract 1995;28(1):9–17. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7587917
   PubMed Web of Science ®Google Scholar
• Ramalho J, Marques C, Pereira P, Mota MC. Crystallin composition of human cataractous lens may be modulated by protein glycation. Graefes Arch Clin Exp Ophthalmol 1996;234 Suppl:S232–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8871180
   Google Scholar
• Olafsdottir E, Andersson DKG, Stefánsson E. The prevalence of cataract in a population with and without type 2 diabetes mellitus. Acta Ophthalmol 2012;90(4):334–40
   PubMedGoogle Scholar
• Pollreisz A, Schmidt-Erfurth U. Diabetic cataract: Pathogenesis, epidemiology and treatment. J Ophthalmol 2010;2010:608751
   PubMed Web of Science ®Google Scholar
• Pinarci EY, Bayar SA, Sizmaz S, Yesilirmak N, Akkoyun I, Yilmaz G. Anterior segment complications after phacovitrectomy in diabetic and nondiabetic patients. Eur J Ophthalmol 2013;23(2):223–9
   PubMedGoogle Scholar
• Takamura Y, Tomomatsu T, Arimura S, et al. Anterior capsule contraction and flare intensity in the early stages after cataract surgery in eyes with diabetic retinopathy. J Cataract Refract Surg 2013;39(5):716–21
   PubMedGoogle Scholar
• Greenberg PB, Tseng VL, Wu WC, et al. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology 2011;118(3):507–14
   PubMed Web of Science ®Google Scholar
• Flesner P, Sander B, Henning V, Parving HH, Dornonville de la Cour M, Lund-Andersen H. Cataract surgery on diabetic patients: A prospective evaluation of risk factors and complications. Acta Ophthalmol Scand 2002;80(1):19–24. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11906299
   PubMedGoogle Scholar
• Dowler JG, Hykin PG, Lightman SL, Hamilton AM. Visual acuity following extracapsular cataract extraction in diabetes: A meta-analysis. Eye (Lond) 1995;9(Pt 3):313–7
   PubMedGoogle Scholar
• Menchini U, Bandello F, Brancato R, Camesasca FI, Galdini M. Cystoid macular oedema after extracapsular cataract extraction and intraocular lens implantation in diabetic patients without retinopathy. Br J Ophthalmol 1993;77(4):208–11. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=504482&tool=pmcentrez&rendertype=abstract
   PubMedGoogle Scholar
• Pollack A, Leiba H, Bukelman A, Abrahami S, Oliver M. The course of diabetic retinopathy following cataract surgery in eyes previously treated by laser photocoagulation. Br J Ophthalmol 1992;76(4):228–31. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=504234&tool=pmcentrez&rendertype=abstract
   PubMedGoogle Scholar
• Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 2007;114(5):881–9
   PubMed Web of Science ®Google Scholar
• Patel JI, Hykin PG, Cree Ia. Diabetic cataract removal: Postoperative progression of maculopathy: Growth factor and clinical analysis. Br J Ophthalmol 2006;90(6):697–701
   PubMedGoogle Scholar
• Ostri C, Lux A, Lund-Andersen H, la Cour M. Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: A 10-year follow-up study. Acta Ophthalmol 2014;92(6):571–6
   PubMedGoogle Scholar
• Ostri C, Lund-Andersen H, Sander B, La Cour M. Phacoemulsification cataract surgery in a large cohort of diabetes patients: Visual acuity outcomes and prognostic factors. J Cataract Refract Surg 2011;37(11):2006–12
   PubMedGoogle Scholar
• Gupta A, Gupta V. Diabetic maculopathy and cataract surgery. Ophthalmol Clin North Am 2001;14(4):625–37. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1771134&tool=pmcentrez&rendertype=abstract
   PubMedGoogle Scholar
• Klein BE, Klein R, Moss SE. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 1985 Sep;92(9):1191–6
   PubMed Web of Science ®Google Scholar
• Rim THT, Kim M-H, Kim WC, Kim T-I, Kim EK. Cataract subtype risk factors identified from the Korea National Health and Nutrition Examination survey 2008–2010. BMC Ophthalmol 2014;14:4
   PubMedGoogle Scholar
• Leske MC, Wu S-Y, Nemesure B, Hennis A. Risk factors for incident nuclear opacities. Ophthalmology 2002;109(7):1303–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12093655
   PubMed Web of Science ®Google Scholar
• Hennis A, Wu S-Y, Nemesure B, Leske MC. Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 2004;122(4):525–30
   PubMedGoogle Scholar
• Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: The Beaver Dam Eye Study. Am J Ophthalmol 1998;126(6):782–90. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9860001
   PubMedGoogle Scholar
• Kanthan GL, Mitchell P, Burlutsky G, Wang JJ. Fasting blood glucose levels and the long-term incidence and progression of cataract: The Blue Mountains Eye Study. Acta Ophthalmol 2011;89(5):e434–8
   Google Scholar
• Richter GM, Choudhury F, Torres M, Azen SP, Varma R. Risk factors for incident cortical, nuclear, posterior subcapsular, and mixed lens opacities: The Los Angeles Latino eye study. Ophthalmology 2012;119(10):2040–7
   PubMedGoogle Scholar
• Stevens A. The contribution of glycation to cataract formation in diabetes. J Am Optom Assoc 1998;69(8):519–30. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9747048
   PubMedGoogle Scholar
• Nagaraj RH, Sady C. The presence of a glucose-derived Maillard reaction product in the human lens. FEBS Lett 1996;382(3):234–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8605976
   PubMedGoogle Scholar
• Nagaraj RH, Monnier VM. Isolation and characterization of a blue fluorophore from human eye lens crystallins: In vitro formation from Maillard reaction with ascorbate and ribose. Biochim Biophys Acta 1992;1116(1):34–42. Available at: http://www.ncbi.nlm.nih.gov/pubmed/1540622
   PubMedGoogle Scholar
• Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997;324(Pt 2):565–70. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1218467&tool=pmcentrez&rendertype=abstract
   PubMed Web of Science ®Google Scholar
• Nagaraj RH, Linetsky M, Stitt AW. The pathogenic role of Maillard reaction in the aging eye. Amino Acids 2012;42(4):1205–20
   PubMedGoogle Scholar
• Peppa M, Uribarri J, Vlassara H. The role of advanced glycation end products in the development of atherosclerosis. Curr Diab Rep 2004;4(1):31–6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14764277
   PubMedGoogle Scholar
• Datiles MB, Kador PF. Type I diabetic cataract. Arch Ophthalmol 1999;117(2):284–5. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10037586
   PubMedGoogle Scholar
• Kumamoto Y, Takamura Y, Kubo E, Tsuzuki S, Akagi Y. Epithelial cell density in cataractous lenses of patients with diabetes: Association with erythrocyte aldose reductase. Exp Eye Res 2007;85(3):393–9
   PubMedGoogle Scholar
• Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 1996;80(9):789–93. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=505613&tool=pmcentrez&rendertype=abstract
   PubMedGoogle Scholar
• Stein J. Serious adverse events after cataract surgery. Curr Opin Ophthalmol 2012 May;23(3):219–225
   PubMed Web of Science ®Google Scholar
• Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995;113(8):1019–29. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7639652
   PubMedGoogle Scholar
• Kim SJ, Belair M-L, Bressler NM, et al. A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina 2008;28(6):870–6
   PubMedGoogle Scholar
• Chew EY, Benson WE, Remaley NA, et al. Results after lens extraction in patients with diabetic retinopathy. Arch Ophthalmol 1999;117:1600–1606
   PubMedGoogle Scholar
• Cetin EN, Yıldırım C. Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery. Int Ophthalmol 2013;33(5):605–10
   PubMedGoogle Scholar
• Davis MD, Fisher R, Gangnon RE, et al. Risk factors for high-risk prolifer ative diabetic retinopathy and severe visual loss. Invest Ophthalmol Vis Sci 1998;39(2):233--52
   PubMed Web of Science ®Google Scholar
• Aiello LM, Wand M, Liang G. Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes mellitus. Ophthalmology 1983;90(7):814–20. Available at: http://www.ncbi.nlm.nih.gov/pubmed/6194491
   PubMedGoogle Scholar
• Benson WE, Brown GC, Tasman W, McNamara JA, Vander JF. Extracapsular cataract extraction with placement of a posterior chamber lens in patients with diabetic retinopathy. Ophthalmology 1993;100(5):730–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8493017
   PubMedGoogle Scholar
• UK Prospective Diabetes Study (UKPDS 33). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837–53. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9742976
   PubMedGoogle Scholar
• The Diabetes Control and Complications Trial. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 1995;113(1):36–51. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7826293
   PubMedGoogle Scholar
• Henricsson M, Nilsson A, Groop L, Heijl A, Janzon L. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control. Acta Ophthalmol Scand 1996;74(6):523–7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9017034
   PubMedGoogle Scholar
• Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract surgery in patients with diabetic retinopathy: Visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 2002;240:735–8
   PubMed Web of Science ®Google Scholar
• Mackool RJ. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1993;115(3):400–2. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8442509
   PubMedGoogle Scholar
• Stein JD, Grossman DS, Mundy KM, Sugar A, Sloan FA. Severe adverse events after cataract surgery among medicare beneficiaries. Ophthalmology 2011;118(9):1716–23
   PubMedGoogle Scholar
• Narendran N, Jaycock P, Johnston RL, et al. The Cataract National Dataset electronic multicentre audit of 55,567 operations: Risk stratification for posterior capsule rupture and vitreous loss. Eye (Lond) 2009;23(1):31–7
   PubMed Web of Science ®Google Scholar
• Moriarty AP, Spalton DJ, Moriarty BJ, Shilling JS, Ffytche TJ, Bulsara M. Studies of the blood-aqueous barrier in diabetes mellitus. Am J Ophthalmol 1994;117(6):768–71. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8198161
   PubMed Web of Science ®Google Scholar
• Ebihara Y, Kato S, Oshika T, Yoshizaki M, Sugita G. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. J Cataract Refract Surg 2006;32(7):1184–7
   PubMed Web of Science ®Google Scholar
• Hayashi K, Hayashi H, Nakao F, Hayashi F. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. Am J Ophthalmol 2002;134(1):10–6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12095802
   PubMed Web of Science ®Google Scholar
• Zaczek A, Zetterström C. Posterior capsule opacification after phacoemulsification in patients with diabetes mellitus. J Cataract Refract Surg 1999;25(2):233–7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9951670
   PubMed Web of Science ®Google Scholar
• Mittra RA, Borrillo JL, Dev S, Mieler WF, Koenig SB. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol 2000;118(7):912–7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10900103
   PubMedGoogle Scholar
• Liao S-B, Ku W-C. Progression of diabetic retinopathy after phacoemulsification in diabetic patients: A three-year analysis. Chang Gung Med J 2003;26(11):829–34. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14765753
   PubMedGoogle Scholar
• Romero-Aroca P, Fernández-Ballart J, Almena-Garcia M, Méndez-Marín I, Salvat-Serra M, Buil-Calvo JA. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: Prospective study. J Cataract Refract Surg 2006;32:1438–1444
   PubMed Web of Science ®Google Scholar
• Squirrell D, Bhola R, Bush J, Winder S, Talbot JF. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 2002;86(5):565–71. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1771134&tool=pmcentrez&rendertype=abstract
   PubMedGoogle Scholar
• Hong T, Mitchell P, de Loryn T, Rochtchina E, Cugati S, Wang JJ. Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery. Ophthalmology 2009;116(8):1510–4
   PubMed Web of Science ®Google Scholar
• Eriksson U, Alm A, Bjärnhall G, Granstam E, Matsson AW. Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls. Graefes Arch Clin Exp Ophthalmol 2011;249(3):349–59
   PubMed Web of Science ®Google Scholar
• Kwon SI, Hwang DJ, Seo JY, Park IW. Evaluation of changes of macular thickness in diabetic retinopathy after cataract surgery. Korean J Ophthalmol 2011;25(4):238–42
   PubMedGoogle Scholar
• Dowler JG, Sehmi KS, Hykin PG, Hamilton AM. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 1999;106(4):663–8
   PubMedGoogle Scholar
• O’Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin 2005;21(7):1131–7
   PubMed Web of Science ®Google Scholar
• Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL. Clinical pseudophakic cystoid macular edema: Risk factors for development and duration after treatment. J Cataract Refract Surg 2007;33(9):1550–8
   PubMedGoogle Scholar
• Singh R, Alpern L, Jaffe GJ, et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clin Ophthalmol 2012;6:1259–69
   PubMedGoogle Scholar
• Elsawy MF, Badawi N, Khairy HA. Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clin Ophthalmol 2013;7:1245–9
   PubMedGoogle Scholar
• Lanzagorta-Aresti A, Palacios-Pozo E, Menezo Rozalen JL, Navea-Tejerina A. Prevention of vision loss after cataract surgery in diabetic macular edema with intravitreal bevacizumab: A pilot study. Retina 2009;29(4):530–5
   PubMedGoogle Scholar
• Takamura Y, Kubo E, Akagi Y. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery. Ophthalmology 2009;116(6):1151–7
   PubMed Web of Science ®Google Scholar
• Cheema RA, Al-Mubarak MM, Amin YM, Cheema MA. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study. J Cataract Refract Surg 2009;35:18–25
   PubMed Web of Science ®Google Scholar
• Akinci A, Batman C, Ozkilic E, Altinsoy A. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract. Retina 2009;29(10):1432–5
   PubMedGoogle Scholar
• Wahab S, Ahmed J. Management of cataract with macular oedema due to diabetes mellitus type-II and hypertension with grid laser prior to surgery and intra-vitreal bevacizumab (Avastin) peroperatively. J Pak Med Assoc 2010;60(10):836–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21381615
   PubMedGoogle Scholar
• Fard MA, Yazdanei Abyane A, Malihi M. Prophylactic intravitreal bevacizumab for diabetic macular edema (thickening) after cataract surgery: Prospective randomized study. Eur J Ophthalmol 2011;21(3):276–81. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20853269
   PubMedGoogle Scholar
• Rauen PI, Ribeiro JAS, Almeida FPP, Scott IU, Messias A, Jorge R. Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema. Retina 2012;32(9):1799–803
   PubMedGoogle Scholar
• Udaondo P, Garcia-Pous M, Garcia-Delpech S, Salom D, Diaz-Llopis M. Prophylaxis of macular edema with intravitreal ranibizumab in patients with diabetic retinopathy after cataract surgery: A pilot study. J Ophthalmol 2011;2011( September 2010):159436
   PubMedGoogle Scholar
• Chae JB, Joe SG, Yang SJ, et al. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy. Retina 2014;34(1):149–56
   PubMedGoogle Scholar
• Lam DSC, Chan CKM, Mohamed S, et al. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: A 6-month prospective pilot study. Eye (Lond) 2005;19(8):885–90
   PubMedGoogle Scholar
• Chew EY, Glassman AR, Beck RW, et al. Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema. Retina 2011;31(2):284–289
   PubMed Web of Science ®Google Scholar
• Takata C, Messias A, Folgosa MS, et al. Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema. Retina 2010;30(4):562–9
   PubMedGoogle Scholar
• Habib MS, Cannon PS, Steel DHW. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract. BMC Ophthalmol 2005;5:15
   PubMedGoogle Scholar
• Kim S-Y, Yang J, Lee Y-C, Park Y-H. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery. J Cataract Refract Surg 2008;34(5):823–6
   PubMedGoogle Scholar